Literature DB >> 16984108

Genetic status of p53 in stomach cancer: somatic mutations and polymorphism of codon 72.

V A Belyavskaya1, V K Vardosanidze, O Yu Smirnova, E I Karakin, I V Savkin, P A Gervas, N V Cherdyntseva, M I Voevoda.   

Abstract

The incidence of somatic mutagenesis of p53 oncosuppressor protein in malignant tumors of the stomach and genetic polymorphism of p53 were studied in patients with stomach cancer on DNA samples isolated from tumor tissues obtained during surgery. The incidence of Pro/Pro genotype increased in the patients, while the percentage of Arg/Pro heterozygotes was markedly lower compared to long-living persons without cancer. The incidence of p53 somatic mutations in exons 5, 7, 8 was 70.8%; multiple mutations were detected in half of the examined patients. The relationship between the intensity of p53 mutagenesis and histological structure of the tumor was detected. The contribution of p53 genetic status to the risk of stomach cancer can be more effectively evaluated on DNA samples isolated from not only tumor cells, but also from normal tissues. The effects of epigenetic factors determining the intensity of somatic mutagenesis of p53 in tumors should be taken into account.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984108     DOI: 10.1007/s10517-006-0139-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  8 in total

1.  Association of p53 codon 72 polymorphism with prostate cancer: a meta-analysis.

Authors:  Yu Zhu; Jing Wang; Qian He; Jun-Qing Zhang
Journal:  Mol Biol Rep       Date:  2010-09-15       Impact factor: 2.316

2.  An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk.

Authors:  Kui-Jie Liu; Hai-Zhi Qi; Hong-Liang Yao; San-Lin Lei; Zhen-Dong Lei; Tie-Gang Li; Hua Zhao
Journal:  Mol Biol Rep       Date:  2012-06-16       Impact factor: 2.316

3.  Genetic mutations of p53 and k-ras in gastric carcinoma patients from Hunan, China.

Authors:  Han-Chun Chen; Hui-Juan Chen; Md Asaduzzaman Khan; Zhou-Zhou Rao; Xin-Xing Wan; Bo Tan; Dian-Zheng Zhang
Journal:  Tumour Biol       Date:  2010-11-16

Review 4.  Signaling pathways and therapeutic interventions in gastric cancer.

Authors:  Zi-Ning Lei; Qiu-Xu Teng; Qin Tian; Wei Chen; Yuhao Xie; Kaiming Wu; Qianlin Zeng; Leli Zeng; Yihang Pan; Zhe-Sheng Chen; Yulong He
Journal:  Signal Transduct Target Ther       Date:  2022-10-08

5.  Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy.

Authors:  Zhao-Hui Huang; Dong Hua; Li-Hua Li; Jing-De Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-21       Impact factor: 4.553

6.  P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies.

Authors:  Shengming Dai; Chen Mao; Lijun Jiang; Guisheng Wang; Hongge Cheng
Journal:  Hum Genet       Date:  2009-04-09       Impact factor: 4.132

Review 7.  Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis.

Authors:  Lei Gao; Alexandra Nieters; Hermann Brenner
Journal:  Eur J Hum Genet       Date:  2009-06-17       Impact factor: 4.246

8.  Duplex Detection of TP53 Arg72Pro and 16 bp Del/Ins Polymorphisms by a Simple Optimized PCR-RFLP Method.

Authors:  B Lajin; A Alachkar; Sakur A Alhaj
Journal:  N Am J Med Sci       Date:  2012-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.